What to Know About a State-of-the-Art Approach to GIST Treatment

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

What to Know About a State-of-the-Art Approach to GIST Treatment

Ronald DeMatteo, MD, of Penn Medicine talks about diagnosis, treatment and research for the rare Gastrointestinal Stromal Tumor (GIST).
  • Sponsored by

  • Overview

    A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan.

    Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio



You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.